Stem Cell Investigation · 2016 · 17 citations · 30 references
MedicineInternal MedicineSurgeryCell TherapyRegenerative MedicineStem Cell TransplantationBone Marrow PhysiologyCell-based TherapiesDiabetes ManagementDiabetes MellitusHematopoietic Stem Cell TransplantationStem Cell MobilizationAutologous Stem Cell TherapyBone Marrow Stem Cell InfusionDiabetes Mellitus ManagementDiabetic ComplicationsFasting Glucose RegulationStem Cell-based TherapyType 2 Diabetes Mellitus TreatmentType 2 Diabetes Treatment
In this study, 6 patients with type 2 diabetes (T2D) underwent autologous bone marrow mononuclear stem cell (BM-MNSC) infusion into the celiac and superior mesenteric arteries without pretreatment with any myeloablative or immune-suppressive therapy. Five of 6 (83%) showed normalization of their fasting glucose and the glycosylated hemoglobin (HbA1C) with significant reduction of their medication requirements. The HbA1C dropped on average 2.2 points. The three patients with diabetic complications showed improvement or stabilization and most patients reported improved energy and stamina. The durations of response varied between 6 months and 2 years. No patients had any significant adverse effects.
30
Sarah H. Wild, Gojka Roglić, Anders Green et al. · Diabetes Care · 2004 · 15.3K citations
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Alexandra E. Butler, Juliette Janson, Susan Bonner‐Weir et al. · Diabetes · 2003 · 4K citations
Medicine, Endocrinology, Physiology +17
Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell
Diane S. Krause, Neil D. Theise, Michael I. Collector et al. · Cell · 2001 · 2.7K citations · Full text
Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030
Gojka Roglić, Anders Green, Richard Sicree et al. · Diabetes Care · 2004 · 1.5K citations